Cargando…

Epi-Off versus Epi-On Corneal Collagen Cross-Linking in Keratoconus Patients: A Comparative Study through 2-Year Follow-Up

AIM: To evaluate two different techniques of cross-linking: standard epithelium-off (CXL epi-off) versus transepithelial (CXL epi-on) cross-linking in patient with progressive keratoconus. METHODS: Forty eyes from 32 patients with progressive keratoconus were prospectively enrolled from June 2014 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cifariello, F., Minicucci, M., Di Renzo, F., Di Taranto, D., Coclite, G., Zaccaria, S., De Turris, S., Costagliola, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087595/
https://www.ncbi.nlm.nih.gov/pubmed/30151277
http://dx.doi.org/10.1155/2018/4947983
_version_ 1783346706204590080
author Cifariello, F.
Minicucci, M.
Di Renzo, F.
Di Taranto, D.
Coclite, G.
Zaccaria, S.
De Turris, S.
Costagliola, C.
author_facet Cifariello, F.
Minicucci, M.
Di Renzo, F.
Di Taranto, D.
Coclite, G.
Zaccaria, S.
De Turris, S.
Costagliola, C.
author_sort Cifariello, F.
collection PubMed
description AIM: To evaluate two different techniques of cross-linking: standard epithelium-off (CXL epi-off) versus transepithelial (CXL epi-on) cross-linking in patient with progressive keratoconus. METHODS: Forty eyes from 32 patients with progressive keratoconus were prospectively enrolled from June 2014 to June 2015 in this nonblinded, randomized comparative study. Twenty eyes were treated by CXL epi-off and 20 by CLX epi-on, randomly assigned, and followed for 2 years. All patients underwent a complete ophthalmologic testing that included uncorrected and best corrected visual acuity, central and peripheral corneal thickness, corneal astigmatism, simulated maximum, minimum, and average keratometry, corneal confocal microscopy, Schirmer I and break-up time (BUT) tests, and the Ocular Surface Disease Index. Intra- and postoperative complications were recorded. The solution used for CXL epi-off comprised riboflavin 0.1% and dextran 20.0% (Ricrolin), whereas the solution for CXL epi-on (Ricrolin TE) comprised riboflavin 0.1%, dextran 15.0%, trometamol (Tris), and ethylenediaminetetraacetic acid. Ultraviolet-A treatment was performed with a UV-X system at 3 mW/cm(2). RESULTS: In both groups, a significant improvement in visual function (Group 1: baseline 0.36 ± 0.16 logMAR, two-year follow-up 0.22 ± 0.17 logMAR, p=0.01; Group 2: baseline 0.32 ± 0.18 logMAR, 2-year follow-up 0.27 ± 0.19 logMAR, p=0.01) was recorded. Keratometry remained unchanged in both groups. The mean corneal thickness showed a significant reduction (mean difference of corneal thickness: −55 micron and −71 micron, resp.). One-month after treatment, OSDI(©) reached 13.56 ± 2.15 in Group 1 (p=0.03) and 11.26 ± 2.12 in Group 2 (p=0.04). At confocal microscopy, abnormal corneal nerve alterations were found in both groups. Fibrotic reaction (43.75%) and activated keratocyte (62.6%) were more commonly recorded in Group 1 than in Group 2 (25.0% and 18.75%), with p=0.668 and 0.356, respectively. CONCLUSION: Our findings demonstrate that both procedures are able to slow keratoconus progression. Both treatment modalities are equivalent in terms of results and related complications. CXL epi-on technique is preferable to CXL epi-off since it preserves the corneal thickness and improves visual acuity, also reducing the postoperative ocular discomfort during the study period.
format Online
Article
Text
id pubmed-6087595
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-60875952018-08-27 Epi-Off versus Epi-On Corneal Collagen Cross-Linking in Keratoconus Patients: A Comparative Study through 2-Year Follow-Up Cifariello, F. Minicucci, M. Di Renzo, F. Di Taranto, D. Coclite, G. Zaccaria, S. De Turris, S. Costagliola, C. J Ophthalmol Clinical Study AIM: To evaluate two different techniques of cross-linking: standard epithelium-off (CXL epi-off) versus transepithelial (CXL epi-on) cross-linking in patient with progressive keratoconus. METHODS: Forty eyes from 32 patients with progressive keratoconus were prospectively enrolled from June 2014 to June 2015 in this nonblinded, randomized comparative study. Twenty eyes were treated by CXL epi-off and 20 by CLX epi-on, randomly assigned, and followed for 2 years. All patients underwent a complete ophthalmologic testing that included uncorrected and best corrected visual acuity, central and peripheral corneal thickness, corneal astigmatism, simulated maximum, minimum, and average keratometry, corneal confocal microscopy, Schirmer I and break-up time (BUT) tests, and the Ocular Surface Disease Index. Intra- and postoperative complications were recorded. The solution used for CXL epi-off comprised riboflavin 0.1% and dextran 20.0% (Ricrolin), whereas the solution for CXL epi-on (Ricrolin TE) comprised riboflavin 0.1%, dextran 15.0%, trometamol (Tris), and ethylenediaminetetraacetic acid. Ultraviolet-A treatment was performed with a UV-X system at 3 mW/cm(2). RESULTS: In both groups, a significant improvement in visual function (Group 1: baseline 0.36 ± 0.16 logMAR, two-year follow-up 0.22 ± 0.17 logMAR, p=0.01; Group 2: baseline 0.32 ± 0.18 logMAR, 2-year follow-up 0.27 ± 0.19 logMAR, p=0.01) was recorded. Keratometry remained unchanged in both groups. The mean corneal thickness showed a significant reduction (mean difference of corneal thickness: −55 micron and −71 micron, resp.). One-month after treatment, OSDI(©) reached 13.56 ± 2.15 in Group 1 (p=0.03) and 11.26 ± 2.12 in Group 2 (p=0.04). At confocal microscopy, abnormal corneal nerve alterations were found in both groups. Fibrotic reaction (43.75%) and activated keratocyte (62.6%) were more commonly recorded in Group 1 than in Group 2 (25.0% and 18.75%), with p=0.668 and 0.356, respectively. CONCLUSION: Our findings demonstrate that both procedures are able to slow keratoconus progression. Both treatment modalities are equivalent in terms of results and related complications. CXL epi-on technique is preferable to CXL epi-off since it preserves the corneal thickness and improves visual acuity, also reducing the postoperative ocular discomfort during the study period. Hindawi 2018-07-29 /pmc/articles/PMC6087595/ /pubmed/30151277 http://dx.doi.org/10.1155/2018/4947983 Text en Copyright © 2018 F. Cifariello et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Cifariello, F.
Minicucci, M.
Di Renzo, F.
Di Taranto, D.
Coclite, G.
Zaccaria, S.
De Turris, S.
Costagliola, C.
Epi-Off versus Epi-On Corneal Collagen Cross-Linking in Keratoconus Patients: A Comparative Study through 2-Year Follow-Up
title Epi-Off versus Epi-On Corneal Collagen Cross-Linking in Keratoconus Patients: A Comparative Study through 2-Year Follow-Up
title_full Epi-Off versus Epi-On Corneal Collagen Cross-Linking in Keratoconus Patients: A Comparative Study through 2-Year Follow-Up
title_fullStr Epi-Off versus Epi-On Corneal Collagen Cross-Linking in Keratoconus Patients: A Comparative Study through 2-Year Follow-Up
title_full_unstemmed Epi-Off versus Epi-On Corneal Collagen Cross-Linking in Keratoconus Patients: A Comparative Study through 2-Year Follow-Up
title_short Epi-Off versus Epi-On Corneal Collagen Cross-Linking in Keratoconus Patients: A Comparative Study through 2-Year Follow-Up
title_sort epi-off versus epi-on corneal collagen cross-linking in keratoconus patients: a comparative study through 2-year follow-up
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087595/
https://www.ncbi.nlm.nih.gov/pubmed/30151277
http://dx.doi.org/10.1155/2018/4947983
work_keys_str_mv AT cifariellof epioffversusepioncornealcollagencrosslinkinginkeratoconuspatientsacomparativestudythrough2yearfollowup
AT minicuccim epioffversusepioncornealcollagencrosslinkinginkeratoconuspatientsacomparativestudythrough2yearfollowup
AT direnzof epioffversusepioncornealcollagencrosslinkinginkeratoconuspatientsacomparativestudythrough2yearfollowup
AT ditarantod epioffversusepioncornealcollagencrosslinkinginkeratoconuspatientsacomparativestudythrough2yearfollowup
AT cocliteg epioffversusepioncornealcollagencrosslinkinginkeratoconuspatientsacomparativestudythrough2yearfollowup
AT zaccarias epioffversusepioncornealcollagencrosslinkinginkeratoconuspatientsacomparativestudythrough2yearfollowup
AT deturriss epioffversusepioncornealcollagencrosslinkinginkeratoconuspatientsacomparativestudythrough2yearfollowup
AT costagliolac epioffversusepioncornealcollagencrosslinkinginkeratoconuspatientsacomparativestudythrough2yearfollowup